Sonic Incytes Medical Corp. logo — Creators of VELACUR: point-of-care AI guided ultrasound elas...

Sonic Incytes Medical Corp.

Creators of VELACUR: point-of-care AI guided ultrasound elastography for chronic liver diseases such as MASLD and MASH

Founded 2017 Canada Canada 41 employees Series A Total: $11.80M Health Care, Medical Devices

General Information

Company Name Sonic Incytes Medical Corp.
Founded Year 2017
Location Canada Canada
Employees 41
Industries Health Care, Medical Devices
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Sonic Incytes Medical Corp.. To contact Sonic Incytes Medical Corp., visit sonicincytes.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Sonic Incytes Medical Corp. compare?

A PDF of Sonic Incytes Medical Corp. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Sonic Incytes Medical Corp. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Sonic Incytes Medical Corp.

Sonic Incytes Medical Corp. is a Canadian-based startup committed to revolutionizing patient care through innovative diagnostic solutions. Their flagship product, VELACUR, is a point-of-care AI-guided ultrasound elastography designed to aid in the management of chronic liver diseases such as MASLD and MASH. This advanced liver imaging tool provides real-time, AI-guided quantification of key markers for fatty liver disease—liver stiffness and attenuation. With an affordable upfront cost and accessibility, VELACUR aims to address the growing epidemic of fatty liver disease by making liver imaging at the point of care more accessible. Founded in 2017, Sonic Incytes operates in the Health Care and Medical Devices industries. The startup recently secured a $7.30M Series A investment on 07 December 2021, backed by an impressive group of investors including Gaingels, INP Capital, MEDTEQ+, Wavemaker 360, MINT Venture Partners, Ginkgo Capital, Nimbus Synergies Inc., and Nicola Wealth Management. This significant investment not only demonstrates confidence in Sonic Incytes' innovative approach to liver disease diagnostics but also provides the necessary financial support for future growth and development.

Business keywords: Point-of-Care Diagnostics, AI Guided Imaging, Ultrasound Elastography, Chronic Liver Diseases, Diagnostic Solutions, Quantitative Ultrasound, Procedure Guidance, Medical Imaging, Fatty Liver Disease, Diagnostic Accuracy

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $7.30M 8
Gaingels, INP Capital +6
07 Dec 2021
Seed Round $3.50M 2
Sunhope Capital, TMFOX
28 May 2020
Non Equity Assistance Undisclosed -
12 Jun 2019
Seed Round $1.00M -
01 Sep 2018
Pre Seed Round Undisclosed -
26 Oct 2016

Sonic Incytes Medical Corp. Alternatives & Competitors

View All Alternatives
Sonic Incytes Medical Corp. vs

Innovations in Ultrasound.

Post-IPO Equity
165 employees
Biotechnology, Health Care
Sonic Incytes Medical Corp. vs

Focused on early detection of liver disease

Post-IPO Equity
25 employees
Biotechnology, Health Care
Sonic Incytes Medical Corp. vs
Livivos, Inc
Livivos, Inc United States

Revolutionary Point-of-Care Liver Disease Diagnostics.

Grant
8 employees
Health Care, Manufacturing

FAQ About Sonic Incytes Medical Corp.

Creators of VELACUR: point-of-care AI guided ultrasound elastography for chronic liver diseases such as MASLD and MASH
Sonic Incytes Medical Corp. was founded in 2017.
Sonic Incytes Medical Corp. is headquartered in Canada.
Sonic Incytes Medical Corp. operates in Health Care and Medical Devices. Its work centres on Point-of-Care Diagnostics, AI Guided Imaging, Ultrasound Elastography and Chronic Liver Diseases.
Sonic Incytes Medical Corp. has approximately 41 employees.
Sonic Incytes Medical Corp. has completed 5 funding rounds, raising a total of $11.80M. The latest funding stage is Series A.
Top alternatives and competitors to Sonic Incytes Medical Corp. include SuperSonic Imagine, ENDRA Life Sciences (Nasdaq: NDRA), Livivos, Inc, Medo.ai, Oncoustics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Sonic Incytes Medical Corp. and SuperSonic Imagine are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Sonic Incytes Medical Corp., https://bouncewatch.com/company/sonic-incytes, updated 7 March 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes